FIELD: medicine. SUBSTANCE: the present innovation deals with selective marking mitochondria of cancer cells due to delivering cationic supravital mitochondrial marking agent towards epithelial cancer cells. Agent, also, may include the reaction product of marking agent and preparation for cancer chemotherapy or be in the mixture with it. The present innovation helps to detect and selectively eliminate cancer cells at the presence of normal ones. EFFECT: higher efficiency of the technique suggested. 10 cl, 9 ex
Authors
Dates
2004-04-10—Published
2001-02-27—Filed